TSPAN17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.361600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.274200E-01
Normal-vs-Stage2
7.802600E-01
Normal-vs-Stage3
5.425800E-01
Normal-vs-Stage4
5.272400E-01
Stage1-vs-Stage2
3.678000E-01
Stage1-vs-Stage3
9.371000E-01
Stage1-vs-Stage4
9.992400E-01
Stage2-vs-Stage3
3.988600E-01
Stage2-vs-Stage4
4.607800E-01
Stage3-vs-Stage4
9.504600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.155200E-01
Normal-vs-AfricanAmerican
2.361200E-01
Normal-vs-Asian
7.083400E-01
Caucasian-vs-AfricanAmerican
3.339400E-01
Caucasian-vs-Asian
1.344390E-01
AfricanAmerican-vs-Asian
8.018100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.889600E-01
Normal-vs-Female
6.812800E-01
Male-vs-Female
7.434400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.181400E-01
Normal-vs-Age(41-60Yrs)
8.297800E-01
Normal-vs-Age(61-80Yrs)
5.565600E-01
Normal-vs-Age(81-100Yrs)
6.976800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.392000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.203400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.010800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.718700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.002600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.908200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.795800E-01
Normal-vs-Daily Drinker
8.995600E-01
Normal-vs-Weekly Drinker
9.614400E-01
Normal-vs-Occasional Drinker
8.548600E-01
Normal-vs-Social Drinker
8.494400E-01
Non Drinker-vs-Daily Drinker
1.815830E-01
Non Drinker-vs-Weekly Drinker
3.174800E-01
Non Drinker-vs-Occasional Drinker
1.326600E-01
Non Drinker-vs-Social Drinker
4.028800E-01
Daily Drinker-vs-Weekly Drinker
7.496400E-01
Daily Drinker-vs-Occasional Drinker
9.993000E-01
Daily Drinker-vs-Social Drinker
5.733200E-01
Weekly Drinker-vs-Occasional Drinker
6.788600E-01
Weekly Drinker-vs-Social Drinker
8.219200E-01
Occasional Drinker-vs-Social Drinker
5.023400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.262600E-01
Normal-vs-Grade 2
1.216390E-01
Normal-vs-Grade 3
7.695900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.241510E-02
Grade 1-vs-Grade 3
2.898000E-03
Grade 1-vs-Grade 4
3.262600E-01
Grade 2-vs-Grade 3
4.651600E-01
Grade 2-vs-Grade 4
1.216390E-01
Grade 3-vs-Grade 4
7.695900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.145200E-01
Normal-vs-NonDiabetic
9.113000E-01
Diabetic-vs-NonDiabetic
1.603560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.099000E-01
Normal-vs-NoPancreatitis
7.324600E-01
Pancreatitis-vs-NoPancreatitis
4.460100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.787200E-01
Normal-vs-N1
6.928000E-01
N0-vs-N1
5.571000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.742200E-01
Normal-vs-TP53-NonMutant
4.663000E-01
TP53-Mutant-vs-TP53-NonMutant
8.372700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
